Abiopharma

News list

Director SULLIVAN FRANK C 🟢 acquired 1.3K shares (1 derivative) of TIMKEN CO (TKR) Transaction Date: May 08, 2026 | Filing ID: 000004

Full text

News bot May 12, 2026, 8:24 p.m.
🔍 SULLIVAN FRANK C (Director)

Company: TIMKEN CO (TKR)

Report Date: 2026-05-08
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 1,280
- Total shares held: 69,467
Detailed Transactions and Holdings:
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-08 | Code: H | shares_owned_after: 69,467.00
- Acquired 1,280 shares of Restricted Share Unit (Derivative)
  Date: 2026-05-08 | Code: A | Expires: 2027-05-08 | equity_swap_involved: 0 | shares_owned_after: 1,280.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Grant of restricted share units that vest 100% one year from date of grant.